TWiV 1134: Clinical update with Dr. Daniel Griffin - podcast episode cover

TWiV 1134: Clinical update with Dr. Daniel Griffin

Jul 27, 202437 minEp. 1134
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

In his weekly clinical update, Dr. Griffin discusses Merck’s RSV preventative monoclonal antibody Clesrovimab before reviewing the recent statistics on SARS-CoV-2 infection, if previous SARS-COV-2 infections predict the outcome of subsequent infections, if using COVID rapid diagnostic tests is cost effective, if the protein based vaccine NVX-CoV2327 elicits a durable immune response, if combination treatment of vaccine and antiviral drugs effectively protect against hospitalization, where to find PEMGARDA, what do when healthcare workers succumb to SARS-CoV-2 infection, and how COVID-19 may alter the cognitive trajectories of older patients.

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
TWiV 1134: Clinical update with Dr. Daniel Griffin | This Week in Virology podcast - Listen or read transcript on Metacast